Background A 60-year-old male with obesity (body-mass index 43 kg/m 2) presented with recurrent symptomatic atrial fibrillation (AF), which he had had since age 41 years. The AF was refractory to ...

A velocity of < 0.4 m/s indicates a higher risk, in general, of thromboembolism. Cardiac CT can be used, as well. During atrial fibrillation and atrial flutter, the left atrial appendage loses ...

Atrial flutter is similar to atrial fibrillation (AF) in regard to symptoms and thromboembolic risk, including stroke. However, the pathophysiology and management differ. Symptoms of AF reflect ...

In this randomized controlled trial, abelacimab led to significantly lower rates of major or clinically relevant nonmajor ...

This leads to stagnant blood in the appendage, which causes clot formation ( thrombosis). Risk factors for atrial fibrillation include: The heart's main pumping chambers, the ventricles ...

Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry. Optimal anti ...

Discover how botanical and nutrient therapies provided adjunctive support for a 76-year-old patient with treatment-resistant ...

In this randomized controlled trial, among patients with atrial fibrillation requiring anticoagulation therapy, asundexian ...

PERIXa protocol shows minimal bleeding risk in AF patients, ensuring safe anticoagulation management for minor procedures.

subclinical atrial fibrillation, venous thromboembolism, or stroke. The risk for major bleeding and intracranial hemorrhage did not differ between apixaban and aspirin (absolute risk difference ...